AAP
ZBH icon

Ardsley Advisory Partners’s Zimmer Biomet ZBH Stock Holding History

Ardsley Advisory Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-128,750
Closed -$14.7M – 238
2015
Q1 		$14.7M Hold
128,750
– – 2.04% 16
2014
Q4 		$14.2M Hold
128,750
– – 2.25% 14
2014
Q3 		$12.6M Buy
+128,750
New +$12.7M 1.66% 18

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Ardsley Advisory Partners's ZBH Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 11,330 shares — an estimated $1.5M sold.

Ardsley Advisory Partners first reported a position in ZBH in Q2 2013 and held it in 21 quarters. The position peaked at $24.4M in Q4 2014. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Ardsley Advisory Partners reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Ardsley Advisory Partners sold 11,330 Zimmer Biomet shares in Q4 2020, an estimated $1.5M.
  • Ardsley Advisory Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Zimmer Biomet position peaked at $24.4M in Q4 2014.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.